Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide), an intermediate capable of synthesizing glibenclamide, exerts an inhibitory effect on the formation of NLRP3 inflammatory vesicles in cardiomyocytes, limiting infarct size after myocardial ischemia/reperfusion in mice and has no effect on metabolism.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 41.00 | |
100 mg | In stock | $ 53.00 | |
200 mg | In stock | $ 76.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide), an intermediate capable of synthesizing glibenclamide, exerts an inhibitory effect on the formation of NLRP3 inflammatory vesicles in cardiomyocytes, limiting infarct size after myocardial ischemia/reperfusion in mice and has no effect on metabolism. |
Synonyms | 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide, NLRP3 Inflammasome Inhibitor I |
Molecular Weight | 368.84 |
Formula | C16H17ClN2O4S |
CAS No. | 16673-34-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 66 mg/mL(178.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NLRP3-IN-2 16673-34-0 Immunology/Inflammation NF-Κb NOD NOD-like Receptor (NLR) infarction inhibit ischemia Inhibitor 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide acute reperfusion NLRP3IN2 myocardial NLRP-3-IN-2 NLRP3 IN 2 NLRP3 Inflammasome Inhibitor I inflammasome inhibitor